Your browser doesn't support javascript.
loading
Second stage human African Trypanosomiasis with Trypanosoma brucei rhodesiense treated with fexinidazole.
Helleberg, Barbara Brask; Gudmundsson, Katrine Snorradottir Steen; Kurtzhals, Jørgen Anders Lindholm; Helleberg, Marie.
  • Helleberg BB; Centre of Excellence for Health, Immunity and Infections, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. Electronic address: barbara.brask.helleberg@regionh.dk.
  • Gudmundsson KSS; Department of Clinical Microbiology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
  • Kurtzhals JAL; Department of Clinical Microbiology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark; Centre for Medical Parasitology, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
  • Helleberg M; Centre of Excellence for Health, Immunity and Infections, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark; Department of Clinical Medicine, University of Copenhagen, Copenhagen
Lancet Infect Dis ; 23(11): e505, 2023 11.
Article en En | MEDLINE | ID: mdl-37890908

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tripanocidas / Tripanosomiasis Africana / Nitroimidazoles Límite: Animals / Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tripanocidas / Tripanosomiasis Africana / Nitroimidazoles Límite: Animals / Humans Idioma: En Año: 2023 Tipo del documento: Article